Zhiyong Hou
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Zhiyong Hou has a total of 627 co-authors. Here are the top co-authors by number of shared publications:
- Yingze Zhang
Nankai University, Tianjin, China
67 shared publications Yingze Zhang
46 shared publicationsLin Jin
Orthopaedic Research Institute of Hebei Province Shijiazhuang People's Republic of China
34 shared publicationsJialiang Guo
Department of Orthopaedic Surgery, The Third Hospital of Hebei Medical University, Shijiazhuang, Hebei, People’s Republic of China
31 shared publicationsTao Wang
Department of Lower Limb Trauma, Beijing Jishuitan Hospital, Guizhou Hospital
30 shared publicationsWei Chen
29 shared publications
Latest Publications
- Open Access
- 1 November 2026
- Published by Taylor & Francis in International Journal of Nanomedicine
- Vol. ume 21, 1-26
Exercise-Derived Skeletal Muscle Exosomes Ameliorate Intervertebral Disc Degeneration and Restore Mitochondrial Homeostasis in Nucleus Pulposus Cells
- 1 November 2026
- Published by Taylor & Francis in International Journal of Nanomedicine
- Vol. ume 21, 1-26
Open AccessExercise-Derived Skeletal Muscle Exosomes Ameliorate Intervertebral Disc Degeneration and Restore Mitochondrial Homeostasis in Nucleus Pulposus Cells
- Open Access
- 1 November 2026
- Published by Taylor & Francis in Clinical Interventions in Aging
- Vol. ume 21, 1-12
Stress Hyperglycemia Ratio and Preoperative Acute Heart Failure in Elderly Hip Fracture Patients with Chronic Cerebrovascular Diseases
Background: The prognostic significance of the stress hyperglycemia ratio (SHR), calculated using admission blood glucose (ABG) and glycated hemoglobin (HbA1c), remains unclear in the context of perioperative complications associated with hip fractures. This study evaluates the association and predictive capability of the SHR for preoperative acute heart failure in hip fracture patients with chronic cerebrovascular disease. Methods and Results: A total of 515 patients were analyzed, revealing a 16.8% incidence of preoperative HF. Significant intergroup differences in age (P < 0.001), ASA classification (P < 0.001), coronary heart disease (P=0.025), serum albumin level (P < 0.001), and admission SHR (P=0.033) were identified between patients with and without preoperative heart failure. Logistic regression identified SHR, CHD, ASA, neutrophils, and hypoproteinemia as independent predictors of preoperative HF, leading to the development of a nomogram that demonstrated good predictive performance (AUC 0.72). Calibration curves and decision curve analysis indicated the model’s clinical utility. Machine learning algorithms, especially the XGBoost model, surpassed traditional models by achieving an AUC of 0.787, demonstrating excellent calibration and clinical applicability. SHAP analysis validated the stable contribution of SHR in risk prediction. Conclusions: This study highlights the SHR’s strong predictive ability for preoperative HF in hip fracture patients with chronic cerebrovascular disease. The XGBoost machine learning model could improve risk stratification and clinical decision-making for this at-risk group.
- 1 November 2026
- Published by Taylor & Francis in Clinical Interventions in Aging
- Vol. ume 21, 1-12
Open AccessStress Hyperglycemia Ratio and Preoperative Acute Heart Failure in Elderly Hip Fracture Patients with Chronic Cerebrovascular Diseases
Background: The prognostic significance of the stress hyperglycemia ratio (SHR), calculated using admission blood glucose (ABG) and glycated hemoglobin (HbA1c), remains unclear in the context of perioperative complications associated with hip fractures. This study evaluates the association and predictive capability of the SHR for preoperative acute heart failure in hip fracture patients with chronic cerebrovascular disease. Methods and Results: A total of 515 patients were analyzed, revealing a 16.8% incidence of preoperative HF. Significant intergroup differences in age (P < 0.001), ASA classification (P < 0.001), coronary heart disease (P=0.025), serum albumin level (P < 0.001), and admission SHR (P=0.033) were identified between patients with and without preoperative heart failure. Logistic regression identified SHR, CHD, ASA, neutrophils, and hypoproteinemia as independent predictors of preoperative HF, leading to the development of a nomogram that demonstrated good predictive performance (AUC 0.72). Calibration curves and decision curve analysis indicated the model’s clinical utility. Machine learning algorithms, especially the XGBoost model, surpassed traditional models by achieving an AUC of 0.787, demonstrating excellent calibration and clinical applicability. SHAP analysis validated the stable contribution of SHR in risk prediction. Conclusions: This study highlights the SHR’s strong predictive ability for preoperative HF in hip fracture patients with chronic cerebrovascular disease. The XGBoost machine learning model could improve risk stratification and clinical decision-making for this at-risk group.
- 22 October 2026
- Published by Springer Nature in International Orthopaedics
- p. 1-9
The early diagnostic value of emergency laboratory indicators in patients with acute compartment syndrome after tibiofibular fractures
Purpose Acute compartment syndrome (ACS) is a serious complication after tibiofibular fractures, which may cause muscle necrosis or even amputation due to challenges in making a prompt diagnosis. Therefore, this study tries to investigate its potential biomarkers from emergency blood tests. Methods Data on patients with tibiofibular fractures from January 2016 to January 2026 were gathered from three Level I trauma centres and categorized into ACS and non-ACS groups. Propensity score matching (PSM) analysis was used to reduce the impact of potential confounding variables. Then, univariate, logistic regression, and ROC curve analyses, as well as a nomogram prediction model, were performed to examine predictors of ACS. Results After PSM analysis, 260 patients were assigned to each group. Even though univariate analysis identified several indicators related to ACS, logistic regression analysis demonstrated that creatine kinase [CK, p < 0.001, OR = 1.003, 95% CI (1.002, 1.004)], creatine kinase myocardial band [CK-MB, p < 0.001, OR = 1.171, 95% CI (1.125, 1.219)], and C-reactive protein [CRP, p < 0.001, OR = 1.259, 95% CI (1.150, 1.377)] are predictors. Furthermore, ROC curve analysis identified 1219.5 U/L, 34.5 U/L, and 13.5 mg/L as the optimal cut-off values to diagnose ACS in patients with tibiofibular fractures. Our model predicts with an AUC of 0.8519 [95% CI (0.8184, 0.8813)], showing consistent calibration and effective clinical application as evidenced by decision curve analysis. Conclusions The levels of CK, CK-MB, and CRP were found to be potential biomarkers for ACS, with their optimal cut-off values identified. Our nomogram prediction model can accurately predict ACS in patients with tibiofibular fractures. We still need large sample data to validate these results.
- 22 October 2026
- Published by Springer Nature in International Orthopaedics
- p. 1-9
The early diagnostic value of emergency laboratory indicators in patients with acute compartment syndrome after tibiofibular fractures
Purpose Acute compartment syndrome (ACS) is a serious complication after tibiofibular fractures, which may cause muscle necrosis or even amputation due to challenges in making a prompt diagnosis. Therefore, this study tries to investigate its potential biomarkers from emergency blood tests. Methods Data on patients with tibiofibular fractures from January 2016 to January 2026 were gathered from three Level I trauma centres and categorized into ACS and non-ACS groups. Propensity score matching (PSM) analysis was used to reduce the impact of potential confounding variables. Then, univariate, logistic regression, and ROC curve analyses, as well as a nomogram prediction model, were performed to examine predictors of ACS. Results After PSM analysis, 260 patients were assigned to each group. Even though univariate analysis identified several indicators related to ACS, logistic regression analysis demonstrated that creatine kinase [CK, p < 0.001, OR = 1.003, 95% CI (1.002, 1.004)], creatine kinase myocardial band [CK-MB, p < 0.001, OR = 1.171, 95% CI (1.125, 1.219)], and C-reactive protein [CRP, p < 0.001, OR = 1.259, 95% CI (1.150, 1.377)] are predictors. Furthermore, ROC curve analysis identified 1219.5 U/L, 34.5 U/L, and 13.5 mg/L as the optimal cut-off values to diagnose ACS in patients with tibiofibular fractures. Our model predicts with an AUC of 0.8519 [95% CI (0.8184, 0.8813)], showing consistent calibration and effective clinical application as evidenced by decision curve analysis. Conclusions The levels of CK, CK-MB, and CRP were found to be potential biomarkers for ACS, with their optimal cut-off values identified. Our nomogram prediction model can accurately predict ACS in patients with tibiofibular fractures. We still need large sample data to validate these results.
- Open Access
- 28 September 2026
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 17, 1846112
Thymic CT attenuation score in SAPHO syndrome: a comparative study with rheumatoid arthritis, ankylosing spondylitis, and healthy controls
Objective: SAPHO syndrome is a rare autoinflammatory/autoimmune overlap disorder whose thymic imaging characteristics remain unexplored. This study evaluated thymic CT attenuation scores in patients with SAPHO syndrome compared with rheumatoid arthritis (RA), ankylosing spondylitis (AS), and healthy controls (HC). Methods: This retrospective study included 180 patients with SAPHO syndrome, 60 with RA, 60 with AS, and 180 HC, all aged ≥30 years. Thymic attenuation was assessed using a 4-point scale (0–3) and CT attenuation values in Hounsfield units (HU). Higher attenuation was defined as score ≥2. Subgroup analyses were performed by sex and age (Post hoc analyses of the ordinal attenuation score and CT attenuation values showed higher values in SAPHO and RA than in AS and HC, whereas SAPHO and RA did not differ significantly from each other. This pattern appeared most pronounced among women aged <45 years, in whom higher attenuation was observed in 54.3% of SAPHO and 47.8% of RA patients, compared with 19.2% of HC and 3.8% of AS patients. Within the SAPHO group, higher attenuation was associated with female sex (85.7% vs 68.5%, P = 0.015) and younger age (median 37.5 vs 44 years, P<0.001). Conclusion: Thymic CT attenuation was higher in SAPHO and RA, particularly among women aged <45 years, whereas AS showed findings similar to HC. Increased thymic attenuation may represent a potential imaging phenotype associated with SAPHO syndrome and RA. Further longitudinal and pathological studies are needed to clarify its biological significance.
- 28 September 2026
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 17, 1846112
Open AccessThymic CT attenuation score in SAPHO syndrome: a comparative study with rheumatoid arthritis, ankylosing spondylitis, and healthy controls
Objective: SAPHO syndrome is a rare autoinflammatory/autoimmune overlap disorder whose thymic imaging characteristics remain unexplored. This study evaluated thymic CT attenuation scores in patients with SAPHO syndrome compared with rheumatoid arthritis (RA), ankylosing spondylitis (AS), and healthy controls (HC). Methods: This retrospective study included 180 patients with SAPHO syndrome, 60 with RA, 60 with AS, and 180 HC, all aged ≥30 years. Thymic attenuation was assessed using a 4-point scale (0–3) and CT attenuation values in Hounsfield units (HU). Higher attenuation was defined as score ≥2. Subgroup analyses were performed by sex and age (Post hoc analyses of the ordinal attenuation score and CT attenuation values showed higher values in SAPHO and RA than in AS and HC, whereas SAPHO and RA did not differ significantly from each other. This pattern appeared most pronounced among women aged <45 years, in whom higher attenuation was observed in 54.3% of SAPHO and 47.8% of RA patients, compared with 19.2% of HC and 3.8% of AS patients. Within the SAPHO group, higher attenuation was associated with female sex (85.7% vs 68.5%, P = 0.015) and younger age (median 37.5 vs 44 years, P<0.001). Conclusion: Thymic CT attenuation was higher in SAPHO and RA, particularly among women aged <45 years, whereas AS showed findings similar to HC. Increased thymic attenuation may represent a potential imaging phenotype associated with SAPHO syndrome and RA. Further longitudinal and pathological studies are needed to clarify its biological significance.
- 23 September 2026
- Published by Springer Nature in International Orthopaedics
- Vol. 50 (12) , 3307-3318
Anticipating femoral shaft nonunion at 1-3 months: a multimodal framework with automated X‑ray segmentation despite metal implants
Background Nonunion is a costly and serious complication in trauma surgery. The RUST score can assess tibial healing on radiographs but offers no prediction of nonunion at nine to 12 months. A prediction model integrating demographics, blood tests, and radiomics fills this gap and brings clinical value. Methods We collected 1-3 month postoperative X-ray, patient data, and blood tests across three centers including 550 patients and 2,344 X-ray. 13 predictive features were selected via two-stage LASSO with group-wise preselection. A U-Net based segmentation framework standardized bone and implant masks under heterogeneous imaging conditions, enabling robust radiomics extraction. ExtraTrees, LightGBM, SVM, CatBoost, Random forest, Gradient boosting, XGBoost, HistGradientBoosting, MLP, Logistic Regression, ElasticNet, Lasso, AdaBoost, Gaussian NB, and Decision Tree were employed to develop NU model. Results A total of 492 patients formed the training cohort and 58 patients formed the external validation cohort. An automated segmentation model achieved mean Dice coefficients of 0.947 for bone/callus and 0.921 for implants. LASSO selected 13 predictors: five radiomic features, seven blood tests, and one clinical variable. The ExtraTrees-based NU model yielded an AUC of 0.891±0.021 in the training cohort, with good calibration and net benefit on decision curve analysis. In external validation, AUC was 0.840. The model enables early nonunion risk stratification within three months after surgery. Conclusion The NU model is the first automated multimodal prediction model integrating radiomics, blood tests, and clinical data to predict femoral shaft nonunion within three months after intramedullary nailing, providing a technically scalable solution for early nonunion risk stratification before conventional imaging becomes diagnostic.
- 23 September 2026
- Published by Springer Nature in International Orthopaedics
- Vol. 50 (12) , 3307-3318
Anticipating femoral shaft nonunion at 1-3 months: a multimodal framework with automated X‑ray segmentation despite metal implants
Background Nonunion is a costly and serious complication in trauma surgery. The RUST score can assess tibial healing on radiographs but offers no prediction of nonunion at nine to 12 months. A prediction model integrating demographics, blood tests, and radiomics fills this gap and brings clinical value. Methods We collected 1-3 month postoperative X-ray, patient data, and blood tests across three centers including 550 patients and 2,344 X-ray. 13 predictive features were selected via two-stage LASSO with group-wise preselection. A U-Net based segmentation framework standardized bone and implant masks under heterogeneous imaging conditions, enabling robust radiomics extraction. ExtraTrees, LightGBM, SVM, CatBoost, Random forest, Gradient boosting, XGBoost, HistGradientBoosting, MLP, Logistic Regression, ElasticNet, Lasso, AdaBoost, Gaussian NB, and Decision Tree were employed to develop NU model. Results A total of 492 patients formed the training cohort and 58 patients formed the external validation cohort. An automated segmentation model achieved mean Dice coefficients of 0.947 for bone/callus and 0.921 for implants. LASSO selected 13 predictors: five radiomic features, seven blood tests, and one clinical variable. The ExtraTrees-based NU model yielded an AUC of 0.891±0.021 in the training cohort, with good calibration and net benefit on decision curve analysis. In external validation, AUC was 0.840. The model enables early nonunion risk stratification within three months after surgery. Conclusion The NU model is the first automated multimodal prediction model integrating radiomics, blood tests, and clinical data to predict femoral shaft nonunion within three months after intramedullary nailing, providing a technically scalable solution for early nonunion risk stratification before conventional imaging becomes diagnostic.
- Open Access
- 22 September 2026
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 17, 1892959
Exercise-responsive endocrine-metabolic mediators in diabetes and cardiometabolic disorders: a systematic scoping review and evidence map
Background: Exercise-responsive endocrine-metabolic mediators may contribute to the systemic cardiometabolic adaptations induced by physical activity, but the literature spans diverse mediator classes, exercise paradigms, disease contexts, and experimental models. We conducted a systematic scoping review and evidence map to characterize the structure of this evidence and the biological relations examined across the field. Methods: PubMed/MEDLINE, Web of Science Core Collection, and Scopus were searched from database inception through 7 August 2026. Titles and abstracts, followed by full texts, were independently assessed by two reviewers, with third-reviewer adjudication where required. Eligible primary reports underwent a separate round of independent full-text data charting using a relational framework linking reports, exercise contrasts, and mediator evidence. Cardiometabolic contexts and outcome domains were coded using multi-label rules, synonymous mediator terminology was harmonized, and companion publications were linked before study-level synthesis. Six potentially co-occurring evidence relations were mapped: exercise responsiveness, cardiometabolic association, source/secretion evidence, receptor/pathway evidence, functional perturbation, and formal mediation. Results: The searches yielded 3,388 records, of which 1,535 unique records underwent title/abstract screening and 397 reports underwent full-text assessment. The final primary evidence map comprised 365 reports representing 363 underlying studies, 413 exercise contrasts, 776 mediator-evidence observations, and 103 harmonized named mediators. Obesity/overweight was represented in 78.0% of studies. Among the 308 studies contributing named mediators, adipokines were represented in 58.4%, cytokines/chemokines in 32.1%, and myokines in 25.6%. Adiponectin, leptin, IL-6, and irisin were the most frequently represented named mediators. Exercise-responsive evidence and cardiometabolic associations were identified in 90.9% and 87.0% of contributing studies, respectively, whereas source/secretion evidence (18.5%), receptor/pathway evidence (9.7%), functional perturbation (11.4%), and formal mediation (0.3%) were less frequently represented. Chronic training accounted for 81.6% of exercise contrasts and aerobic/endurance exercise for 63.4%. Conclusions: Exercise-responsive mediator research in cardiometabolic disease comprises a concentrated group of recurrent adipokines, cytokines, and myokines alongside a broad, sparsely studied mediator landscape. Exercise-responsive evidence and cardiometabolic associations were frequently represented, whereas direct investigation of tissue source, downstream pathways, functional perturbation, and formal mediation was less common. Studies integrating well-characterized exercise exposures with serial mediator assessment, source validation, and mechanistic testing may help define how exercise-responsive signaling contributes to cardiometabolic adaptation.
- 22 September 2026
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 17, 1892959
Open AccessExercise-responsive endocrine-metabolic mediators in diabetes and cardiometabolic disorders: a systematic scoping review and evidence map
Background: Exercise-responsive endocrine-metabolic mediators may contribute to the systemic cardiometabolic adaptations induced by physical activity, but the literature spans diverse mediator classes, exercise paradigms, disease contexts, and experimental models. We conducted a systematic scoping review and evidence map to characterize the structure of this evidence and the biological relations examined across the field. Methods: PubMed/MEDLINE, Web of Science Core Collection, and Scopus were searched from database inception through 7 August 2026. Titles and abstracts, followed by full texts, were independently assessed by two reviewers, with third-reviewer adjudication where required. Eligible primary reports underwent a separate round of independent full-text data charting using a relational framework linking reports, exercise contrasts, and mediator evidence. Cardiometabolic contexts and outcome domains were coded using multi-label rules, synonymous mediator terminology was harmonized, and companion publications were linked before study-level synthesis. Six potentially co-occurring evidence relations were mapped: exercise responsiveness, cardiometabolic association, source/secretion evidence, receptor/pathway evidence, functional perturbation, and formal mediation. Results: The searches yielded 3,388 records, of which 1,535 unique records underwent title/abstract screening and 397 reports underwent full-text assessment. The final primary evidence map comprised 365 reports representing 363 underlying studies, 413 exercise contrasts, 776 mediator-evidence observations, and 103 harmonized named mediators. Obesity/overweight was represented in 78.0% of studies. Among the 308 studies contributing named mediators, adipokines were represented in 58.4%, cytokines/chemokines in 32.1%, and myokines in 25.6%. Adiponectin, leptin, IL-6, and irisin were the most frequently represented named mediators. Exercise-responsive evidence and cardiometabolic associations were identified in 90.9% and 87.0% of contributing studies, respectively, whereas source/secretion evidence (18.5%), receptor/pathway evidence (9.7%), functional perturbation (11.4%), and formal mediation (0.3%) were less frequently represented. Chronic training accounted for 81.6% of exercise contrasts and aerobic/endurance exercise for 63.4%. Conclusions: Exercise-responsive mediator research in cardiometabolic disease comprises a concentrated group of recurrent adipokines, cytokines, and myokines alongside a broad, sparsely studied mediator landscape. Exercise-responsive evidence and cardiometabolic associations were frequently represented, whereas direct investigation of tissue source, downstream pathways, functional perturbation, and formal mediation was less common. Studies integrating well-characterized exercise exposures with serial mediator assessment, source validation, and mechanistic testing may help define how exercise-responsive signaling contributes to cardiometabolic adaptation.
- Open Access
- 10 September 2026
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 13, 1910778
A combined score based on anterior chest wall CT attenuation to aid recognition of SAPHO syndrome: a training-validation study
Objective: To investigate whether quantitative anterior chest wall CT attenuation can aid recognition of SAPHO syndrome, to develop a simple combined score, and to evaluate its discriminatory performance in a validation set. Methods: We retrospectively enrolled 260 patients with SAPHO syndrome and 260 age- and sex-matched healthy controls. CT attenuation values were measured at five sites: the left and right clavicular heads, the left and right upper manubrium, and the sternal angle, and were normalized to the CT attenuation of an internal reference vertebra. Using stratified random sampling (7:3), the total sample was divided into a training set (364 cases: 182 SAPHO and 182 controls) and a validation set (156 cases: 78 SAPHO and 78 controls). In the training set, ROC analysis was used to compare individual ratios and additive combinations, establish the combined score, and determine the optimal cutoff. The fixed cutoff was then applied to the validation set. In addition, a subgroup analysis was performed in SAPHO patients without obvious anterior chest wall CT morphological changes. Results: In the training set, the combined score achieved an AUC of 0.980 (95% CI: 0.969–0.991). At the optimal cutoff of >5.412, sensitivity and specificity were both 93.41%. In the validation set, using the same cutoff, the AUC was 0.976 (95% CI: 0.958–0.993), with a sensitivity of 92.3% and a specificity of 84.6%. Among 96 SAPHO patients without obvious anterior chest wall CT morphological changes, 81 (84.4%) had combined scores above the fixed cutoff; the AUC for distinguishing this subgroup from healthy controls was 0.956 (95% CI: 0.935–0.974). Conclusion: The combined score based on multi-site anterior chest wall CT attenuation demonstrated high discriminatory ability between SAPHO patients and healthy controls and showed consistent performance in the internal validation set. In patients without obvious anterior chest wall CT morphological changes, the score provided additional quantitative imaging information and may serve as an objective complement to conventional morphological assessment.
- 10 September 2026
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 13, 1910778
Open AccessA combined score based on anterior chest wall CT attenuation to aid recognition of SAPHO syndrome: a training-validation study
Objective: To investigate whether quantitative anterior chest wall CT attenuation can aid recognition of SAPHO syndrome, to develop a simple combined score, and to evaluate its discriminatory performance in a validation set. Methods: We retrospectively enrolled 260 patients with SAPHO syndrome and 260 age- and sex-matched healthy controls. CT attenuation values were measured at five sites: the left and right clavicular heads, the left and right upper manubrium, and the sternal angle, and were normalized to the CT attenuation of an internal reference vertebra. Using stratified random sampling (7:3), the total sample was divided into a training set (364 cases: 182 SAPHO and 182 controls) and a validation set (156 cases: 78 SAPHO and 78 controls). In the training set, ROC analysis was used to compare individual ratios and additive combinations, establish the combined score, and determine the optimal cutoff. The fixed cutoff was then applied to the validation set. In addition, a subgroup analysis was performed in SAPHO patients without obvious anterior chest wall CT morphological changes. Results: In the training set, the combined score achieved an AUC of 0.980 (95% CI: 0.969–0.991). At the optimal cutoff of >5.412, sensitivity and specificity were both 93.41%. In the validation set, using the same cutoff, the AUC was 0.976 (95% CI: 0.958–0.993), with a sensitivity of 92.3% and a specificity of 84.6%. Among 96 SAPHO patients without obvious anterior chest wall CT morphological changes, 81 (84.4%) had combined scores above the fixed cutoff; the AUC for distinguishing this subgroup from healthy controls was 0.956 (95% CI: 0.935–0.974). Conclusion: The combined score based on multi-site anterior chest wall CT attenuation demonstrated high discriminatory ability between SAPHO patients and healthy controls and showed consistent performance in the internal validation set. In patients without obvious anterior chest wall CT morphological changes, the score provided additional quantitative imaging information and may serve as an objective complement to conventional morphological assessment.
- Open Access
- 1 September 2026
- Published by Taylor & Francis in Journal of Inflammation Research
- Vol. ume 19, 1-15
Neutrophil-Dominant Inflammatory Responses and Inflammation-Coagulation Burden After Extremity Acute Compartment Syndrome: A Retrospective Multi-Cohort Study
Background: Extremity acute compartment syndrome (ACS) is a pressure-related surgical emergency accompanied by ischemic muscle injury. Whether routinely available inflammatory and coagulation markers characterize outcome-relevant host-response patterns remains unclear. Methods: We retrospectively analyzed 852 ACS-related patients, hospitalizations, or critical-care stays across three cohorts. The primary analysis included 227 patients with traumatic extremity ACS and examined early baseline inflammatory and coagulation profiles in relation to limb-specific adverse outcomes. Local inflammatory phenotype and post-baseline trajectory analyses were exploratory. Medical Information Mart for Intensive Care IV (MIMIC-IV; n=415) and eICU Collaborative Research Database (eICU; n=210) served as supportive critical-care cohorts for systemic outcomes and were not used for external validation of local limb-specific findings. Results: In the local cohort, muscle necrosis occurred in 85 patients (37.4%), amputation or muscle necrosis in 87 (38.3%), infection in 35 (15.4%), thrombosis in 29 (12.8%), and any adverse outcome in 109 (48.0%). Higher neutrophil and white blood cell counts were associated with any adverse outcome, muscle necrosis, and amputation or muscle necrosis. These associations remained directionally consistent after additional consideration of American Society of Anesthesiologists physical status, injury-to-hospital time, and, among decompressed patients, injury-to-decompression time. A principal-component-derived inflammation-coagulation axis was associated with adverse limb and thrombotic outcomes. Exploratory analyses identified a neutrophil-dominant inflammatory phenotype and heterogeneous post-baseline trajectories. Supportive MIMIC-IV and eICU analyses showed associations between systemic inflammatory burden and selected systemic outcomes. Conclusion: In the primary local cohort, extremity ACS was accompanied by measurable inflammatory host-response patterns associated with adverse outcomes. Phenotype and trajectory findings were exploratory. Public critical-care cohorts provided supportive systemic-outcome context but did not externally validate the local limb-specific findings. Prospective studies with standardized sampling and clinical covariate ascertainment are needed before these markers can be considered for clinical risk assessment or decision-making.
- 1 September 2026
- Published by Taylor & Francis in Journal of Inflammation Research
- Vol. ume 19, 1-15
Open AccessNeutrophil-Dominant Inflammatory Responses and Inflammation-Coagulation Burden After Extremity Acute Compartment Syndrome: A Retrospective Multi-Cohort Study
Background: Extremity acute compartment syndrome (ACS) is a pressure-related surgical emergency accompanied by ischemic muscle injury. Whether routinely available inflammatory and coagulation markers characterize outcome-relevant host-response patterns remains unclear. Methods: We retrospectively analyzed 852 ACS-related patients, hospitalizations, or critical-care stays across three cohorts. The primary analysis included 227 patients with traumatic extremity ACS and examined early baseline inflammatory and coagulation profiles in relation to limb-specific adverse outcomes. Local inflammatory phenotype and post-baseline trajectory analyses were exploratory. Medical Information Mart for Intensive Care IV (MIMIC-IV; n=415) and eICU Collaborative Research Database (eICU; n=210) served as supportive critical-care cohorts for systemic outcomes and were not used for external validation of local limb-specific findings. Results: In the local cohort, muscle necrosis occurred in 85 patients (37.4%), amputation or muscle necrosis in 87 (38.3%), infection in 35 (15.4%), thrombosis in 29 (12.8%), and any adverse outcome in 109 (48.0%). Higher neutrophil and white blood cell counts were associated with any adverse outcome, muscle necrosis, and amputation or muscle necrosis. These associations remained directionally consistent after additional consideration of American Society of Anesthesiologists physical status, injury-to-hospital time, and, among decompressed patients, injury-to-decompression time. A principal-component-derived inflammation-coagulation axis was associated with adverse limb and thrombotic outcomes. Exploratory analyses identified a neutrophil-dominant inflammatory phenotype and heterogeneous post-baseline trajectories. Supportive MIMIC-IV and eICU analyses showed associations between systemic inflammatory burden and selected systemic outcomes. Conclusion: In the primary local cohort, extremity ACS was accompanied by measurable inflammatory host-response patterns associated with adverse outcomes. Phenotype and trajectory findings were exploratory. Public critical-care cohorts provided supportive systemic-outcome context but did not externally validate the local limb-specific findings. Prospective studies with standardized sampling and clinical covariate ascertainment are needed before these markers can be considered for clinical risk assessment or decision-making.